Impact of Center for Personalized Diagnostics (CPD) Genomic Testing


Related Videos (117)

Marilyn Schapira, MD, MPH, offers an overview of the oncology genomic testing program at the Center for Personalized Diagnostics at Penn Medicine, which includes comprehensive heme-NGS and solid tumor panels for somatic mutations in AML, brain tumors, GI malignancies, lung malignancies, and melanoma. Dr. Schapira’s discussion also delves into the factors that influence the uptake of CPD testing and treatment decisions among physicians who use the CPD.


Penn PhysicianLink®

Penn PhysicianLink® is an exclusive program that helps all referring physicians connect with Penn Medicine. This comprehensive package of support services expedites and facilitates direct physician communication for patient consults, referrals and transfers.

Learn more about Penn PhysicianLink®